News + Font Resize -

Janssen Pharmaceutica Products receives Subpoena on Risperdal
New Jersey | Tuesday, January 27, 2004, 08:00 Hrs  [IST]

Janssen Pharmaceutica Products, LP, has received a subpoena from the US Office of Personnel Management, Office of the Inspector General requesting documents related to Risperdal (risperidone), a prescription medication approved to treat schizophrenia and bipolar mania. The company is cooperating in responding to the subpoena. The company is a subsidiary of Johnson & Johnson.

Post Your Comment

 

Enquiry Form